Prognosis in children with Wilms' tumor metastases prior to or following primary treatment Results from the first National Wilms' Tumor Study (NWTS-1)
Patterns of Care Outcome Survey
An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy A later analysis
Prognostic factors in medulloblastoma
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy
AMSA and peptichemio in the treatment of advanced metastatic breast cancer
Phase II trial of bruceantin in metastatic breast carcinoma
Splenectomy in Hodgkin's disease
Multidrug chemotherapy (vincristine-bleomycin-methotrexate) followed by radiotherapy in inoperable carcinomas of the head and neck A pilot study of the Radiation Therapy Oncology Group
A phase I trial of aziridinylbenzoquinone (NSC 182986) in patients with previously treated acute leukemia
Phase II study of 5-azacytidine in sarcomas of bone
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1 -nitrosourea
Chemotherapy for malignant mesothelioma
Phase II study of m-AMSA in advanced malignant melanoma
Subacute vincristine toxicity following five consecutive daily doses
Mitomycin C
Age as a criterion for eligibility in a lung cancer clinical trial
Dibromodulcitol in the treatment of metastatic hemangiopericytoma
Prostatic Cancer
Role of Medroxyprogesterone in Endocrine-Related Tumors
Neurofibromatosis (Von Recklinghausen Disease) Genetics, Cell Biology, and Biochemistry
Malignancy and the Hemostatic System
Carcinogenic Hormones
E.O.R.T.C. Symposium on Paraneoplasia Basic Concepts and Clinical Aspects
To the Editor
To the Editor